IPD vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

48LOW

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

IPD PAR
Technical
57
53
Catalyst
55
51
Sentiment
50
50
Fundamental
95
60
Momentum
30
42
Risk Gate
27
50

Key Metrics

IPD Metric PAR
$22.0MMarket Cap$99.4M
6.9MAvg Volume (20d)2.2M
N/AShort InterestN/A
$0.05952-Week High$0.470
$0.00552-Week Low$0.135
+0.0%Daily Change-7.4%
$0.006Entry Price$0.162
-117.9%ROE-180.2%
-171.3%Profit MarginN/A

Active Signals

IPD Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+25%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Drifting lower — down 4.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (11766.1x)
●Strong revenue growth (+51%)

Ask Scout AI to compare IPD and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IPD Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).